2016, Number 2
Prevalence of metabolic syndrome in patients attended to Internal Medicine consultation
Language: Spanish
References: 28
Page: 190-201
PDF size: 168.49 Kb.
ABSTRACT
The metabolic syndrome is related with an incresse of diabetes risk, coronary illness and illness cerebrovascular for what constitutes a problem of health that can be reverted, if we diagnose it and we use the rehabilitation on time.Objective: to determine the prevalence of the metabolic syndrome in the patients of the consultation of internal medicine of the University Hospital ¨Dr. Carlos J. Finlay¨ in the period of January to December of the 2013.
Method: he/she was carried out a longitudinal descriptive study in 500 patients coming from the medicine consultation, of January to December of the 2013. For the diagnosis he/she was carried out physical exam (I weigh, it carves, index of corporal mass, arterial tension, abdominal circumference) and laboratory tests (cholesterol, triglycerides, glicemia). For the statistical prosecution they were used technical descriptive, the test of square Chi of Pearson. For the quantitative variables it was used the test of Student and K. Wallis. Did he/she take as level of statistical significance a value p ≤ 0,05, interval of trust to 95 %.
Results: the prevalence of 15,6 % was demonstrated (78 patients), carried out in 500 patients that went to the medicine consultation in the outlined period.
REFERENCES
Parlá Sardiñas J., Cabrera Rode E., Marichal Madrazo S., Arranz Calzado C., Domínguez Alonso E., González Fernández P., Vera González M. Frecuencia y caracterización del síndrome metabólico según criterios de la Federación Internacional de Diabetes en familiares de primer grado de personas con diabetes tipo 1. Rev Cubana Endocrinol. 2011;22(3):196-209. Disponible en: http://scielo.sld.cu
Fernandez-Berges D., Cabrera de León A., Sanz H., Elosua R., Guembe M. J., Alzamora M., Vega-Alonso T., Félix-Redondo F. J., Ortiz-Marron H., Rigo F., Lama C., Gavrila D., Segura-Fragoso A., Lozano L. y Marrugatd J. Síndrome metabólico en España: prevalencia y riesgo coronario asociado a la definición armonizada y a la propuesta por la OMS. Rev Esp Cardiol. 2012;65(3):241-4.
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome. A Joint Interm Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5.
Kassi E., Pervanidou P., Kaltsas G. and Chrousos G. Metabolic syndrome: definitions and controversies. BMC Medicine. 2011, 9:48 Disponible en: http://www.biomedcentral.com/1741-7015/9/48 10. Pérez Cynthia M., Guzmán M., Ortiz A. P., Estrella M., Valle Y., Pérez N., Haddock L., and Suárez E. Prevalence of the Metabolic Syndrome in San Juan, Puerto Rico. Ethn. Dis. 2008;18(4): 434-41. 11. Qiong Bai. Xuan Lai. Ai-Hua Zhang. Xin-Hong Lu. Shun-Li Tian. Min-Hua Fan. Yue Wang. Tao Wang. Metabolic syndrome and its components associated with endothelial dysfunction in chronic kidney disease patients. Vascular Health and Risk Management. 2012;8;15-21. 12. Jover A., Corbella E., Muñoz A., Millán J., Pinto X., Mangas A., Zúñiga M., Pedro-Botet J. y Hernández-Mijares A. Prevalencia del síndrome metabólico y de sus componentes en pacientes con síndrome coronario agudo. Rev Esp Cardiol. 2011; 64(7):579-86. 13. Quirantes Moreno AJ; López Ramírez M; Hernández Meléndez E; Pérez Sánchez A. Estilo de vida, desarrollo científico-técnico y obesidad. Rev Cubana Salud Pública. 2009;35(3). 14. Yamaoka K. and Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. Yamaoka and Tango BMC Medicine. 2012, 10:138. Disponible en: http://www.biomedcentral.com/1741- 7015/10/138 15. Devi Pratyush D., Tiwari S., Singh S., and Kumar Singh S. Waist circumference cutoff and its importance for diagnosis of metabolic syndrome in Asian Indians: A preliminary study. Indian J Endocrinol Metab 2012 Jan-Feb;16(1):112–5. 16. Pérez Fariñas L. Pérez Rodríguez ZM. Mora González SR, Guerrero Delgado L. Tratamiento de pacientes con obesidad abdominal como prevención o progresión del síndrome metabólico. Rev Cubana Med Fis Rehab. 2014 Sep;6(1). Disponible en: http://bvs.sld.cu/revistas/mfr/vol6n1_14/mfr04114.htm 17. Matienzo Pino Y. Pérez Rodríguez ZM, Arpa Gámez A., Morales Jiménez E. Utilidad del tratamiento con corriente Kotz y cama magnética en pacientes con síndrome metabólico Rev Cubana Med Fis Rehab. 2015 Ene;7(2) Disponible en:http://bvs.sld.cu/revistas/mfr/vol7n2_15/mfr 18. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome. A Joint Interm Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5. 19. Kaushik P., Soumik G., Sujoy G., Pradip M., and Subhankar C. Metabolic syndrome in South Asians. Indian. J Endocrinol Metab. 2012 Jan-Feb;16(1): 44-55. 20. Hamdy Ahmed S., Seham A., Nader N., and Iman E. Metabolic syndrome in the Middle East. Indian J Endocrinol Metab. 2012 Jan-Feb;16(1): 67–71. 21. Kassi E., Pervanidou P., Kaltsas G. and Chrousos G. Metabolic syndrome: definitions and controversies. BMC Medicine. 2011, 9:48 Disponible en: http://www.biomedcentral.com/1741-7015/9/48 Revista Cubana de Medicina Física y Rehabilitación 2016;8(2):190-201 http://www.sld.cu/sitios/revrehabilitacion/ 201
Bayturan O.; Murat Tuzcu E.; Lavoie A.; Hu Tingfei; Wolski K.; Schoenhagen P.; Kapadia S.; Nissen Steven E.; Nicholls Stephen J. The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Arch Intern Med. 2010; 170(5):478-84. Disponible en: www.archinternmed.com